Related Experiment Video
Updated: May 30, 2025

10:16
Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
1.0K
PathoGD: an integrative genomics approach to primer and guide RNA design for CRISPR-based diagnostics
Soo Jen Low1,2, Matthew O'Neill3,4, William J Kerry4
1Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. soojen.low@unimelb.edu.au.
Communications Biology
|January 30, 2025
Summary
PathoGD automates the design of CRISPR-Cas12a diagnostic tools for pathogen detection. This bioinformatic pipeline rapidly generates specific primers and guide RNAs (gRNAs) for accurate identification of infectious agents.
Area of Science:
- Bioinformatics
- Molecular Diagnostics
- Genomics
Background:
- CRISPR-based diagnostics require highly specific target selection for accurate pathogen identification.
- Manual design of diagnostic targets is time-consuming and requires iterative optimization.
Purpose of the Study:
- To develop an automated bioinformatic pipeline, PathoGD, for rapid and high-throughput design of primers and guide RNAs (gRNAs).
- To facilitate the development of CRISPR-Cas12a-based diagnostic assays for detecting clinically relevant bacterial pathogens.
Main Methods:
- PathoGD leverages publicly available genomic sequences for automated primer and gRNA design.
- The pipeline is scalable for large datasets, enabling continuous monitoring and validation of assay components.
- Experimental validation was performed for Streptococcus pyogenes and Neisseria gonorrhoeae detection.
Main Results:
- PathoGD successfully designed primers and gRNAs for five bacterial pathogens.
- Experimental validation confirmed high specificity and minimal off-target signals for designed primer and gRNA sets.
- The pipeline demonstrated efficacy in detecting target pathogens with and without pre-amplification.
Conclusions:
- PathoGD offers a rapid and automated solution for designing CRISPR-Cas12a diagnostic assay components.
- The pipeline ensures ongoing assay relevance through continuous monitoring and validation.
- PathoGD is a valuable resource for developing diagnostic tools for current and emerging pathogens.

